FDA Approves PREGABALIN — Eskayef Pharmaceuticals Limited

# FDA Approves Pregabalin Generic from Eskayef Pharmaceuticals Eskayef Pharmaceuticals Limited received FDA approval for its generic pregabalin oral formulation (ANDA212988), adding another competitor to the widely-prescribed neuropathic pain and seizure disorder market and likely intensifying price competition in the pregabalin segment. The approval expands generic alternatives for pregabalin, potentially increasing accessibility while pressuring margins for existing manufacturers in this established therapeutic category.